Dátum ex-dividendy spoločnosti IMV

Aká je hodnota metriky Dátum ex-dividendy spoločnosti IMV?

Hodnota metriky Dátum ex-dividendy spoločnosti IMV, Inc. je N/A

Aká je definícia metriky Dátum ex-dividendy?



Dátum ex-dividendy (Ex-dividend date) je dátum, ktorý určuje či budú dividendy vyplatené predávajúcemu alebo kupujúcemu. Vyplatené dividendy za akcie kúpené po ex-dividend dátumom patria novému majiteľovi.

The ex-dividend date or reinvestment date is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings. If a sale is before this date, the dividend belongs to the new owner; if on or after the date, the seller is entitled to the dividend. If a stock is purchased on its ex-dividend date or after, the buyer will not receive the next dividend payment. Instead, the seller gets the dividend. If a stock is purchased before the ex-dividend date, the buyer gets the dividend.

Čomu sa venuje spoločnosť IMV?

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.